A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
Centre Leon Berard
University of Michigan Rogel Cancer Center
University of Colorado, Denver
Oslo University Hospital
Oslo University Hospital
Northwestern University
City of Hope Medical Center
University of Michigan Rogel Cancer Center
National Taiwan University Hospital
Institut Bergonié
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University of Utah
M.D. Anderson Cancer Center
Institut Claudius Regaud
Sanford Health
University Health Network, Toronto
Instituto do Cancer do Estado de São Paulo
Columbia University
Fox Chase Cancer Center